The ER-mitochondria interface in astrocytes during METH exposure and HIV-1 infection
METH 暴露和 HIV-1 感染期间星形胶质细胞中的 ER-线粒体界面
基本信息
- 批准号:10259195
- 负责人:
- 金额:$ 3.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Astrocytes are key regulators of CNS health and neuronal function. Astrocyte mitochondrial dysfunction,
such as induced by HIV-1 and METH, threatens the provision of essential metabolic and antioxidant support to
neurons. Thus, delineating regulatory pathways that can be targeted to prevent aberrant mitochondria
homeostasis in astrocytes will be imperative for ensuring neuronal fitness/survival against CNS pathologies.
Direct contact sites between the endoplasmic reticulum (ER) and the mitochondria, termed mitochondrial
associated membranes (MAMs), are central hubs for regulating several cellular processes required for
homeostasis, including mitochondrial metabolic activity. In fact, the transfer of Ca2+ from the ER to mitochondria
is essential for mitochondrial bioenergetics. Recent investigations have also identified unique, yet ill-defined
contributions of the three unfolded protein response (UPR) arms in regulating MAM tethering and/or signaling.
Briefly, protein kinase RNA-like endoplasmic reticulum kinase (PERK) has been determined as a key regulator
for MAM tethering, inositol-requiring kinase 1 (IRE1α) is implicated in regulating MAM-mediated Ca2+ transfer,
and activating transcription factor 6 (ATF6) is suspected to participate in MAM formation as it is known to mediate
ER elongation and lipid homeostasis. However, these regulatory mechanisms have not yet been fully elucidated.
Moreover, while modifications in MAM tethering and signaling have been involved in a number of
neurodegenerative pathologies, their presence and participation in astrocyte biology remains to be determined.
We hypothesize the ER-mitochondria interface is a key mediator of astrocyte mitochondrial dysfunction
via Ca2+ and non-canonical UPR signaling during HIV-1 and METH pathogenesis.
The proposed studies will examine changes in astrocyte mitochondrial function, UPR induction, Ca2+
signaling, and MAM formation in response to METH exposure and HIV-1 infection, followed by the delineation
of ER-associated mechanisms regulating astrocyte mitochondrial function, and thus metabolic and antioxidant
capacity. Aim 1 will evaluate how METH exposure and HIV-1 infection alter astrocyte metabolic and antioxidant
capacity. Aim 2 will investigate how the ER-mitochondria interface regulates HIV-1/METH-mediated astrocyte
mitochondrial dysfunction. Based on our preliminary findings, we propose to prioritize investigating the roles of
PERK and IRE1α in regulating MAM tethering and MAM-mediated Ca2+ transfer, respectively, and how these
functions alter astrocyte mitochondrial capacity. These studies will implement pharmacological inhibitors, specific
silencing (si)RNAs and overexpression vectors to determine how UPR induction, Ca2+ signaling, and MAM
tethering regulate astrocyte mitochondrial health during HIV-1/METH pathogenesis. These findings will help
identify underlying mechanisms mediating astrocyte mitochondria dysfunction, which can be therapeutically
targeted to optimize the metabolic and antioxidant coupling between astrocytes and neurons to promote neuronal
survival during neurodegenerative pathologies.
星形胶质细胞是CNS健康和神经元功能的关键调节剂。星形细胞线粒体功能障碍,
例如HIV-1和METH诱导的,威胁要提供必需的代谢和抗氧化剂支持
神经元。这是划定可以针对的监管途径,以防止异常线粒体
星形胶质细胞中的稳态必须确保对CNS病理的神经元健康/生存。
内质网(ER)和线粒体之间的直接接触位点称为线粒体
相关机制(MAM)是控制几个蜂窝过程所需的中心枢纽
稳态,包括线粒体代谢活性。实际上,Ca2+从ER转移到线粒体
对于线粒体生物能力是必不可少的。最近的投资还确定了独特但定义不明的
在调节MAM绑扎和/或信号传导中,三个展开的蛋白质反应(UPR)臂的贡献。
简而言之,蛋白激酶RNA样性内质网激酶(PERK)已确定为关键调节剂
对于MAM绑扎,肌醇含量的激酶1(IRE1α)与调节MAM介导的Ca2+转移有关
并怀疑激活转录因子6(ATF6)参与MAM形成,因为已知会介导
ER伸长和脂质稳态。但是,这些调节机制尚未完全阐明。
此外,尽管MAM绑扎和信号传导的修改涉及许多
神经退行性病理,它们的存在和参与星形胶质细胞生物学仍有待确定。
我们假设er-ritochontria界面是星形胶质细胞功能障碍的关键介体
通过HIV-1和METH发病机理期间的Ca2+和非经典UPR信号传导。
拟议的研究将检查星形胶质细胞线粒体功能的变化,UPR诱导,Ca2+
信号传导和MAM形成,以响应甲基甲基暴露和HIV-1感染,然后进行描述
ER相关的机制,用于标准线粒体功能,因此代谢和抗氧化剂
容量。 AIM 1将评估甲基甲基暴露和HIV-1感染如何改变星形胶质细胞代谢和抗氧化剂
容量。 AIM 2将研究ER-线粒体界面如何调节HIV-1/METH介导的星形胶质细胞
线粒体功能障碍。根据我们的初步发现,我们建议优先研究
PERK和IRE1α在调节MAM链接和MAM介导的Ca2+转移中,以及如何分别
功能会改变星形胶质细胞线粒体能力。这些研究将实施药物抑制剂,特定
沉默(SI)RNA和过表达向量,以确定UPR诱导,Ca2+信号传导和MAM
束缚在HIV-1/METH发病机理期间调节星形胶质细胞的线粒体健康。这些发现将有所帮助
识别介导星形胶质细胞线粒体功能障碍的潜在机制,可以热
旨在优化星形胶质细胞和神经元之间的代谢和抗氧化剂耦合以促进神经元
神经退行性病理学期间的生存。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Jessica Michelle P...的其他基金
The ER-mitochondria interface in astrocytes during METH exposure and HIV-1 infection
METH 暴露和 HIV-1 感染期间星形胶质细胞中的 ER-线粒体界面
- 批准号:1040131510401315
- 财政年份:2021
- 资助金额:$ 3.5万$ 3.5万
- 项目类别:
相似海外基金
Mentoring in cholinergic regulation of vascular oxidation
血管氧化的胆碱能调节的指导
- 批准号:1066476810664768
- 财政年份:2023
- 资助金额:$ 3.5万$ 3.5万
- 项目类别:
A Diet Intervention Study To Mitigate Fatigue Symptoms And To Improve Muscle And Physical Function In Older Adults With Post-Acute COVID-19 Syndrome
一项饮食干预研究,旨在减轻患有急性后 COVID-19 综合症的老年人的疲劳症状并改善肌肉和身体功能
- 批准号:1073498110734981
- 财政年份:2023
- 资助金额:$ 3.5万$ 3.5万
- 项目类别:
56th Annual Meeting of the Society for Leukocyte Biology
白细胞生物学学会第 56 届年会
- 批准号:1075209010752090
- 财政年份:2023
- 资助金额:$ 3.5万$ 3.5万
- 项目类别:
Targeting microglial cell iron-handling in Alzheimer’s Disease
靶向阿尔茨海默病中的小胶质细胞铁处理
- 批准号:1060399210603992
- 财政年份:2023
- 资助金额:$ 3.5万$ 3.5万
- 项目类别:
Long acting biodegradable buprenorphine depots
长效可生物降解丁丙诺啡储库
- 批准号:1075718010757180
- 财政年份:2023
- 资助金额:$ 3.5万$ 3.5万
- 项目类别: